Taurolidine has previously been shown to enhance Fas-Ligand mediated cell death [15] and a xenograft study using recombinant TNF in the treatment of mouse fibrosarcoma revealed that Taurolidine reduced the toxicity of TNF without decreasing the anti-tumor efficacy of TNF [16]. This evidence concerns the gene TNF and fibrosarcoma.